Clinic Features and Outcome of BPD (SGBPD)

Clinic Features and Long-term Outcome of Different Subgroups of Brochopulmonary Dysplasia in Preterm Infants

NCT04237844•Wang Jianhui

Summary

This study described the perinatal high-risk factors and clinical manifestations of the children, and compared the high-risk factors, clinical manifestations and prognosis of BPD among different clinical subtypes by comparison between groups. BPD grading was performed using the 2018 grading standard to compare the distribution of I/II/III BPD among different groups.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Premature infants born at \<32 weeks of gestational age;
•2. hospitalization time ≥ 14 days;
•3. The clinical medical records are complete

Exclusion Criteria

•• 1) Children with congenital heart, lung malformation and definite chromosomal diseases; 2) children gave up treatment halfway; 3) corrected gestational age 36 weeks before death, the cause of death was confirmed as factors other than respiratory system.

Locations (1)

Children's hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China

Key Dates

Start Date

December 1, 2020

Primary Completion Date

October 30, 2021

Completion Date

December 30, 2021

Last Updated

November 23, 2021

Enrollment

300

ESTIMATED participants

Conditions

Bronchopulmonary Dysplasia

IVIG Trial for the Treatment of Bronchopulmonary Dysplasia

NCT06925360

Bronchopulmonary Dysplasia

View study

RECRUITING

Reversibility of Bronchial Obstruction in Children Born Preterm

NCT06110481

Bronchopulmonary DysplasiaChronic Lung Disease of Prematurity+5 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 23, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Clinic Features and Outcome of BPD (SGBPD)

Inclusion Criteria

Exclusion Criteria

IVIG Trial for the Treatment of Bronchopulmonary Dysplasia

Reversibility of Bronchial Obstruction in Children Born Preterm

The Role of Volatile Organic Compounds (VOCs), Airway Mucins and the Microbiome in the Early Prediction of Bronchopulmonary Dysplasia (BPD)

Gastric Feeding Versus Transpyloric Feeding in Infants with Severe Bronchopulmonary Dysplasia, a Crossover Study

Comparison of INRECSURE and LISA in Preterm Neonates With RDS

Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia